Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Claritev (CTEV) Income towards Parent Company (2019 - 2025)

Claritev (CTEV) has 6 years of Income towards Parent Company data on record, last reported at -$150.5 million in Q4 2025.

  • For Q4 2025, Income towards Parent Company rose 19.14% year-over-year to -$150.5 million; the TTM value through Dec 2025 reached -$243.9 million, up 50.82%, while the annual FY2025 figure was -$284.3 million, 82.73% up from the prior year.
  • Income towards Parent Company reached -$150.5 million in Q4 2025 per CTEV's latest filing, down from -$93.4 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $78.2 million in Q3 2021 and bottomed at -$309.7 million in Q3 2024.
  • Average Income towards Parent Company over 5 years is -$56.1 million, with a median of $209000.0 recorded in 2023.
  • The widest YoY moves for Income towards Parent Company: up 1868.58% in 2021, down 3415.4% in 2021.
  • A 5-year view of Income towards Parent Company shows it stood at $25.0 million in 2021, then decreased by 21.01% to $19.7 million in 2022, then plummeted by 955.73% to -$168.9 million in 2023, then dropped by 10.2% to -$186.1 million in 2024, then grew by 19.14% to -$150.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Income towards Parent Company were -$150.5 million in Q4 2025, -$93.4 million in Q3 2025, and -$186.1 million in Q4 2024.